Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ascendis Health's Enterprise Value is R435 Mil.
Ascendis Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was R-239 Mil. Therefore, Ascendis Health's EV-to-EBIT ratio for today is -1.82.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ascendis Health's Enterprise Value is R435 Mil.
Ascendis Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was R-239 Mil. Therefore, Ascendis Health's EV-to-EBITDA ratio for today is -1.82.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ascendis Health's Enterprise Value is R435 Mil.
Ascendis Health's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was R1,535 Mil. Therefore, Ascendis Health's EV-to-Revenue ratio for today is 0.28.
Ascendis Health Enterprise Value Historical Data
The historical data trend for Ascendis Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ascendis Health's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Ascendis Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascendis Health's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ascendis Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Ascendis Health's Enterprise Value falls into.
Ascendis Health Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Ascendis Health's Enterprise Value for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascendis Health (JSE:ASC) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Ascendis Health's current Enterprise Value is R435 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ascendis Health's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was R-239 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Ascendis Health's current Enterprise Value is R435 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ascendis Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was R-239 Mil.
Ascendis Health's current Enterprise Value is R435 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ascendis Health's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was R1,535 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascendis Health Enterprise Value Related Terms
Thank you for viewing the detailed overview of Ascendis Health's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
JSE:ASC has been successfully added to your 